Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Dyne Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 1,390 shares
@ $12.43, valued at
$17.3k
Sold 40,000 shares
@ $12.89, valued at
$515.6k
Sold 10,000 shares
@ $12.03, valued at
$120.3k
Exercised 40,000 options to buy
@ $1.03, valued at
$41.2k
|
|
| 06/12/2023 |
4
| Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Gifted 20,000 shares
@ $0
Gifted 1,800 shares
@ $0
Sold 46,811 shares
@ $13.15, valued at
$615.6k
Sold 14,189 shares
@ $13.47, valued at
$191.1k
Sold 76,582 shares
@ $13.34, valued at
$1M
Sold 187,748 shares
@ $12.61, valued at
$2.4M
Exercised 30,088 options to buy
@ $1.03, valued at
$31k
Exercised 76,582 options to buy
@ $1.03, valued at
$78.9k
Exercised 171,360 options to buy
@ $1.03, valued at
$176.5k
|
|
| 05/25/2023 |
4
| Stehman-Breen Catherine (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 05/25/2023 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 05/25/2023 |
4
| Lubner David Charles (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 05/25/2023 |
4
| Kersten Dirk (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 05/25/2023 |
4
| Incerti Carlo (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 05/25/2023 |
4
| HURWITZ EDWARD (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 24,900 options to buy
@ $13.49, valued at
$335.9k
|
|
| 03/15/2023 |
4
| Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 1,311 shares
@ $13.33, valued at
$17.5k
|
|
| 03/15/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 1,000 shares
@ $13, valued at
$13k
Sold 1,209 shares
@ $13.33, valued at
$16.1k
|
|
| 03/15/2023 |
4
| HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 1,559 shares
@ $13.33, valued at
$20.8k
|
|
| 03/15/2023 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 7,441 shares
@ $13.33, valued at
$99.2k
|
|
| 03/15/2023 |
4
| Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 7,318 shares
@ $13.33, valued at
$97.5k
|
|
| 03/15/2023 |
4
| Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 1,416 shares
@ $13.33, valued at
$18.9k
|
|
| 01/23/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $14.03, valued at
$140.3k
Exercised 10,000 options to buy
@ $0.73, valued at
$7.3k
|
|
| 01/11/2023 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 30,150 shares
@ $11.57, valued at
$348.8k
|
|
| 12/14/2022 |
4
| Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Bought 934,581 shares
@ $10.7, valued at
$10M
|
|
| 12/14/2022 |
4
| Atlas Venture Opportunity Fund II, L.P. (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Bought 934,581 shares
@ $10.7, valued at
$10M
|
|
| 12/13/2022 |
4
| Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 31,000 shares
@ $0
Sold 312 shares
@ $10.87, valued at
$3.4k
Granted 45,000 options to buy
@ $10.72, valued at
$482.4k
|
|
| 12/13/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Sold 472 shares
@ $10.87, valued at
$5.1k
Granted 63,000 options to buy
@ $10.72, valued at
$675.4k
|
|
| 12/13/2022 |
4
| HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 44,000 shares
@ $0
Sold 751 shares
@ $10.87, valued at
$8.2k
Granted 69,000 options to buy
@ $10.72, valued at
$739.7k
|
|
| 12/13/2022 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 36,000 shares
@ $0
Sold 628 shares
@ $10.87, valued at
$6.8k
Granted 56,000 options to buy
@ $10.72, valued at
$600.3k
|
|
| 12/13/2022 |
4
| Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 144,000 shares
@ $0
Sold 3,322 shares
@ $10.87, valued at
$36.1k
Granted 222,000 options to buy
@ $10.72, valued at
$2.4M
|
|
| 12/13/2022 |
4
| Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Sold 680 shares
@ $10.87, valued at
$7.4k
Granted 63,000 options to buy
@ $10.72, valued at
$675.4k
|
|
| 10/11/2022 |
4
| Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Sold 14,200 shares
@ $13.37, valued at
$189.9k
Sold 195,800 shares
@ $12.46, valued at
$2.4M
Gifted 13,000 shares
@ $0
Gifted 2,500 shares
@ $0
Exercised 14,200 options to buy
@ $1.03, valued at
$14.6k
Exercised 195,800 options to buy
@ $1.03, valued at
$201.7k
|
|
| 09/21/2022 |
4
| Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 840 shares
@ $13.7, valued at
$11.5k
|
|
| 09/21/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 1,246 shares
@ $13.7, valued at
$17.1k
|
|
| 09/21/2022 |
4
| HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 2,629 shares
@ $13.7, valued at
$36k
|
|
| 09/21/2022 |
4
| Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 11,836 shares
@ $13.7, valued at
$162.2k
|
|
| 09/21/2022 |
4
| Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 1,413 shares
@ $13.7, valued at
$19.4k
|
|
| 09/15/2022 |
4
| Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 326 shares
@ $14.05, valued at
$4.6k
|
|
| 09/15/2022 |
4
| Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 658 shares
@ $14.05, valued at
$9.2k
|
|
| 09/15/2022 |
4
| McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 494 shares
@ $14.05, valued at
$6.9k
|
|
| 09/15/2022 |
4
| HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Disposed/sold 786 shares
@ $14.05, valued at
$11k
|
|
|
|
|